Global Urinary Catheters Market - Strategic Insights and Forecasts (2026-2031)

Global Urinary Catheters Market is projected to register a strong CAGR during the forecast period (2026-2031).

The global urinary catheters market is currently recording a structural pivot as the rising prevalence of chronic multimorbidity forces a surge in long-term urinary management. Healthcare systems are responding to this volume pressure by enlisting "nurse-led removal algorithms," which are successfully reducing catheter retention rates from 30% to 6.7% in specific post-operative cohorts. This transition is becoming critical as the CDC’s 2026 surveillance modules are currently forcing hospitals to adopt stricter CAUTI reporting, which directly impacts reimbursement under value-based purchasing models. Regulatory influence is expanding through the EU Medical Device Regulation (MDR) and a planned phase-out of DEHP, currently forcing producers to enlist sustainable, phthalate-free biomaterials. Consequently, the industry is reaching a structural outcome where the home-care channel is forecast to expand rapidly, outpacing traditional hospital growth.

Market Dynamics

Drivers

• Geriatric Multimorbidity: The aging population is currently fueling a significant projected rise in individuals with multiple chronic conditions, sustaining base demand for drainage solutions.

• Reimbursement Alignment: New 2026 HCPCS codes are successfully enlisting premium adoption by providing better payer coverage for intermittent hydrophilic catheters.

• Self-Catheterization Education: Manufacturers are currently enlisting digital education and patient empowerment programs to drive adherence in the fast-growing home healthcare segment.

• Surgical Volume Recovery: Increasing global surgical procedures are currently increasing the routine use of perioperative catheterization in acute care settings.

Restraints and Opportunities

• Financial Penalties for CAUTI: Preventable harm associated with indwelling devices is currently forcing a shift toward non-catheter therapies for incontinence.

• Tariff-Induced Cost Pressures: Import duties on medical-grade silicone and precision extrusion equipment are currently raising procurement costs in North America and Europe.

• Skin-Tone Agnostic Monitoring (Opportunity): Companies are currently enlisting integrated lubrication packets and antimicrobial alloys to gain a competitive edge in long-term care.

• Female External Systems (Opportunity): The introduction of non-invasive female external urine-management devices is currently carving a preventive role by eliminating insertion trauma.

Supply Chain Analysis

The urinary catheter supply chain is currently transitioning from "Bulk Commodity" to "Value-Added Specialty" as producers enlist precision extrusion and advanced coating technologies. Suppliers are successfully enlisting integrated "Interventional Urology" portfolios, yet firms like Teleflex are currently divesting these units to streamline operational focus. This evolution is becoming critical as the market is reaching an outcome where dependence on imported raw materials is currently increasing device prices in tariff-sensitive regions.

Government Regulations

Key Developments

• Teleflex Restructuring Plan (March 2026): Teleflex initiated a multi-year plan expected to achieve $50 million in annual pre-tax cost savings, starting in 2026.

• Coloplast Acquisition of Uromedica (Feb 2026): Coloplast successfully agreed to purchase Uromedica to expand its presence in the treatment of stress urinary incontinence.

Market Segmentation

By Catheter Type

Indwelling Catheters currently lead the market, yet they are facing structural pressure from new infection-prevention mandates. Intermittent Catheters are projected to log the fastest growth through 2031 as they are successfully enlisting user convenience and lower dwell times for self-management. This transition is resulting in an outcome where external catheters are reaching a structural role in preventing insertion trauma across gender lines.

By Application

Urinary Incontinence accounted for a considerable share in 2025, driven by high-volume demand for both intermittent and external devices. Spinal Cord Injury demand is advancing rapidly as clinicians are enlisting long-term management solutions to prevent neurogenic bladder complications. Consequently, the segment is reaching a structural outcome where BPH applications are becoming a vital driver for specialized Foley stabilization devices.

By End-User

Hospitals currently capture a significant percentage of revenue, but they are enlisting rapid-removal algorithms to minimize CAUTI penalties. Home Healthcare is forecast to expand rapidly, as enterprises are reducing on-premise care in favor of e-commerce-enabled self-catheterization. This shift is forcing an outcome where long-term care facilities are reaching a structural reliance on silicone-based and coated catheters to ensure patient comfort.

Regional Analysis

North America remains the largest market, due to well-established reimbursement scenarios for premium devices. Asia-Pacific is currently identified as the fastest-growing region, where local manufacturers and global leaders are successfully forming partnerships to bolster supply chains in India and China. This movement is resulting in a structural outcome where Europe is reaching a reliance on high-accuracy compliance with the EU MDR to sustain regional market access.

List of Companies

• B. Braun Melsungen AG

• Boston Scientific Corporation

• Medtronic

• Coloplast Corp

• ConvaTec Inc.

• Cook Medical

• C. R. Bard, Inc. (BD)

• Teleflex Incorporated

• Bactiguard Holding

• Hollister Incorporated

Company Profiles

• Coloplast Corp: Strategically distinct for its "Micro-hole Zone Technology," the company is successfully enlisting its Luja™ catheter to drive 7% organic growth in its Continence Care business.

• Teleflex Incorporated: Notable for its transformation plan, the company is currently divesting its Interventional Urology business to focus on core high-acuity medical technologies.

• Bactiguard Holding: Distinguished by its licensing model, the company is successfully enlisting partnerships with BD and Zimmer Biomet to deploy its infection-preventive coating globally.

Analyst View

The global urinary catheters market is entering an "Infection-Agnostic" phase. Success for participants now depends on successfully enlisting hydrophilic coatings and "non-invasive first" external designs to satisfy 2026 reimbursement updates and avoid CAUTI-related hospital penalties through 2031.

Global Urinary Catheters Market Scope: